ADCT icon

ADC Therapeutics

58 hedge funds and large institutions have $273M invested in ADC Therapeutics in 2022 Q2 according to their latest regulatory filings, with 15 funds opening new positions, 15 increasing their positions, 9 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more call options, than puts

Call options by funds: $ | Put options by funds: $

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more funds holding

Funds holding:

0.46% more ownership

Funds ownership: 44.43%44.88% (+0.46%)

46% less capital invested

Capital invested by funds: $501M → $273M (-$229M)

67% less funds holding in top 10

Funds holding in top 10: 31 (-2)

Holders
58
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$198K
Puts
$117K
Net Calls
Net Calls Change

Top Buyers

1 +$5.09M
2 +$1.29M
3 +$1.11M
4
Morgan Stanley
Morgan Stanley
New York
+$951K
5
Principal Financial Group
Principal Financial Group
Iowa
+$802K

Top Sellers

1 -$3.99M
2 -$3.93M
3 -$756K
4
VEA
Virtus ETF Advisers
New York
-$282K
5
AA
ALPS Advisors
Colorado
-$264K
Name Holding Trade Value Shares
Change
Change in
Stake
51
$2K
52
$1.33K
53
$1K
54
$795
55
56
57
58